Global Next Generation Sequencing (NGS) Market Growth, Trends & Forecasts (2016 - 2021) - Product Image

Global Next Generation Sequencing (NGS) Market Growth, Trends & Forecasts (2016 - 2021)

  • ID: 3784811
  • Report
  • Region: Global
  • 123 pages
  • Mordor Intelligence
1 of 4

FEATURED COMPANIES

  • Agilent Technologies
  • Dnastar
  • Genomatix Software Gmbh
  • Knome
  • Pacific Biosciences
  • Qiagen
  • MORE
The Global market for Next Generation Sequencing is poised to reach $10 billion by the end of 2020 growing at a CAGR of approximately 20%. The instruments and consumables is the largest segment with a share of around half of the market in 2013. The fastest growing segment is the services with a highest CAGR during the forecast period. The major players are interested in services segment as it provides additional revenue for the company at the same time, increases the sales of instruments and reagents. The major players operating in the NGS market are Illumina Inc (U.S.), Thermo Fisher Scientific (U.S.), Hoffmann-La Roche Ltd (Switzerland), Pacific Bioscieces (U.S.) Agilent Technologies (U.S.), BGI (Beijing Genomics Institute) (China), Qiagen (Netherlands), Biomatters Ltd (New Zealand), and Genomatix Software GmbH (Germany).

Currently, North America is the largest market for NGS. This is due to the increased awareness about the quick return of investments and accuracy. Asia Pacific is the fastest growing segment. The Next Generation Sequencing market can be segmented on the basis of Technology (Whole Genome Sequencing, Targeted Resequencing, Whole Exome Sequencing, RNA Sequencing, Chip Sequencing, De Novo Sequencing and Methyl Sequencing), Products (Instruments, Reagents & Consumables, and Services), End user (Hospitals & Healthcare Institutions, Academics, Biotech & Pharma Firms, and Others), Applications (Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture And Animal Research, Infectious Diseases, and Others) and Geography (North America, Europe, APAC & RoW).

Drivers

Increasing applications in clinical diagnosis boosting the market growth, Speed, cost and accuracy to spur the market growth, Efficient replacement for traditional technologies (Microarrays), and Drug discovery applications demanding NGS technology are the major factors driving the growth of the market.

Restraints

Legal & ethical issues to hamper the market growth, Interpretation of complex data, and Lack of skilled professionals are the major restraints that are hampering the NGS market growth.

What the report offers

- Market Definition for the specified topic along with identification of key drivers and restraints for the market.
- Market analysis for the Global Next Generation Sequencing Market, with region specific assessments and competition analysis on a global and regional scale.
- Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
- Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.�
- Identification and analysis of the Macro and Micro factors that affect the Global Next Generation Sequencing market on both global and regional scale.
- A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Please note: As this product is updated at the time of order, dispatch will be 72 hours from the date the order and full payment is received
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Agilent Technologies
  • Dnastar
  • Genomatix Software Gmbh
  • Knome
  • Pacific Biosciences
  • Qiagen
  • MORE
INTRODUCTION
  • Study Deliverables
  • Market Definition
  • Sizing Units
  • Base Currency
  • Review and forecast period years
  • General Study Assumptions
RESEARCH METHODOLOGY
  • Introduction
  • Analysis Methodology
  • Econometric forecast models
  • Research Assumptions
EXECUTIVE SUMMARY

KEY INFERENCES

MARKET OVERVIEW AND INDUSTRY TRENDS
  • Current market scenario
  • Technology Overview
  • New developments in therapeutics
  • Investment analysis
  • Porters Five Force Analysis
  • Bargaining Power of suppliers
  • Bargaining power of buyers
  • Degree of competition
  • Threat of substitution
  • Threat of new entrants
DRIVERS, RESTRAINTS, OPPORTUNITIES
  • Market Drivers
  • Increasing applications in clinical diagnosis boosting the market growth
  • Speed, cost and accuracy to spur the market growth
  • Efficient replacement for traditional technologies (Microarrays)
  • Drug discovery applications demanding NGS technology
  • Market Restraints
  • Legal & ethical issues to hamper the market growth
  • Interpretation of complex data
  • Lack of skilled professionals
  • Market Opportunities
  • In NGS Technology, Personalized Medicine & Biomarker
  • Pre-Sequencing
  • Cloud Computing
  • Key Challenges
  • Interpretation Of Complex Data From NGS Platforms
  • Clinical Translation of Genomic Discoveries
GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION
  • By Technology
  • Whole Genome Sequencing
  • Targeted Resequencing
  • Whole Exome Sequencing
  • Rna Sequencing
  • Chip Sequencing
  • De Novo Sequencing
  • Methyl Sequencing
  • By Products
  • Instruments
  • Reagents & Consumables
  • By End Users
  • Services
  • Hospitals & Healthcare Institutions
  • Academics
  • Biotech & Pharma Firms
  • Others
  • By Application
  • Drug Discovery
  • Genetic Screening
  • Diagnostics
  • Personalized Medicine
  • Agriculture And Animal Research
  • Infectious Diseases
  • Others
GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY GEOGRAPHY - REGIONAL SHARES AND FORECAST
  • North America
  • USA
  • Canada
  • Mexico
  • Europe
  • France
  • UK
  • Germany
  • Spain and Portugal
  • Scandinavia
  • Italy
  • BENELUX
  • Asia-Pacific
  • India
  • China
  • Japan
  • South Korea
  • Australia and New Zealand
  • Rest of Asia Pacific
  • Middle East and Africa
  • GCC
  • Egypt
  • Morocco
  • Algeria
  • South Africa
  • Rest of Middle East and Africa
  • Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
COMPETITIVE LANDSCAPE
  • Merger and Acquisition Analysis
  • Patent Analysis
  • The Challengers
KEY VENDORS
  • Roche Holding Ag
  • Agilent Technologies, Inc
  • BGI (Beijing Genomics Institute)
  • Biomatters, Ltd
  • Qiagen
  • Dnastar, Inc
  • Gatc Biotech Ag
  • Genomatix Software Gmbh
  • Illumina, Inc
  • Knome, Inc
  • Thermo Fisher Scientific
  • Macrogen, Inc
  • Oxford Nanopore Technologies, Ltd
  • Pacific Biosciences
  • Partek Incorporated
  • Perkin Elmer, Inc
ANALYST OUTLOOK FOR INVESTMENT OPPORTUNITIES

FUTURE OUTLOOK OF THE MARKET

APPENDIX
  • Abbreviations
  • Bibliography
  • Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Roche Holding Ag
Agilent Technologies
BGI (Beijing Genomics Institute)
Biomatters
Qiagen
Dnastar
Gatc Biotech Ag
Genomatix Software Gmbh
Illumina
Knome
Thermo Fisher Scientific
Macrogen
Oxford Nanopore Technologies
Pacific Biosciences
Parte
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll